|
|
News for Healthier Living
Dana-Farber Presents Phase 3 Lung Cancer Data in ESMO Presidential Symposium
Dana-Farber Cancer Institute researchers will present findings at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain. The studies, including a lung cancer clinical trial featured in the Presidential Symposium, will be presented both in-person and online from October 23 to October 27. Additional studies with compelling results span multiple cancer types, including prostate, breast, and kidney.
October 20, 2026
October 29 2026October 28 2026October 27 2026October 26 2026October 25 2026October 24 2026October 23 2026October 22 2026October 21 2026October 20 2026October 19 2026October 18 2026October 17 2026October 16 2026
|
|
|
|
|